Evolocumab Prescribing at MAYFLOWER MEDICAL GROUP
Lipid-regulating drugs | Cardiovascular System
Items (12m)
127
Total Quantity
278
NHS Cost
£47.3K
vs National Avg
+615.9%
MAYFLOWER MEDICAL GROUP prescribed 127 items of Evolocumab over the last 12 months at a cost of £47,289 to the NHS. This is 615.9% above the national average prescribing rate. Evolocumab is classified under Lipid-regulating drugs in the BNF.
Monthly Prescribing Trend
Jul 2026
10
Jul 2026
10
Jul 2026
10
Jul 2026
12
Jul 2026
9
Jul 2026
13
Jul 2026
7
Jul 2026
10
Jul 2026
10
Jul 2026
15
Jul 2026
10
Jul 2026
11
Prescribing Details
| Total Items | 127 |
|---|---|
| Total Quantity | 278 |
| Total NHS Cost | £47,289 |
| Presentations | 1 different forms |
| vs National Average | +615.9% |
Evolocumab Prescribing Comparison
| This practice | 127 items |
|---|---|
| National average per practice | 18 items |
| Difference | +615.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.